Plant Health Care PLC
LSE:PHC
Plant Health Care PLC
LSE:PHC
Price:
4.16 GBX
-8.57%
Market Closed
Updated:
May 13, 2024
Plant Health Care PLC
Cost of Revenue
|
Plant Health Care PLC
Cost of Revenue Peer Comparison
Comparables:
CF
FMC
CTVA
SMG
MOS
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Plant Health Care PLC
LSE:PHC
|
Cost of Revenue
-$4.7m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-9%
|
|
|
CF Industries Holdings Inc
NYSE:CF
|
Cost of Revenue
-$4B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
FMC Corp
NYSE:FMC
|
Cost of Revenue
-$2.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
|
Corteva Inc
NYSE:CTVA
|
Cost of Revenue
-$9.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Scotts Miracle-Gro Co
NYSE:SMG
|
Cost of Revenue
-$2.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-4%
|
|
|
Mosaic Co
NYSE:MOS
|
Cost of Revenue
-$10.8B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-4%
|
See Also
What is Plant Health Care PLC's Cost of Revenue?
Cost of Revenue
-4.7m
USD
-4.7m
USD
Based on the financial report for Jun 30, 2023, Plant Health Care PLC's Cost of Revenue amounts to -4.7m USD.
What is Plant Health Care PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-9%
-9%
Over the last year, the Cost of Revenue growth was -16%. The average annual Cost of Revenue growth rates for Plant Health Care PLC have been -16% over the past three years , -10% over the past five years , and -9% over the past ten years .
You don't have any saved screeners yet
